The Institute of Diabetes and Regeneration Research at Helmholtz Zentrum München and Eli Lilly and Company (Lilly) have partnered with the goal of improving and accelerating the treatment of diabetes mellitus. Diabetes mellitus’s long-term complications and co-morbidities represent one of the most devastating and urgent threats to society. While significant progress has been made in...
New pooled data from the Phase 2 and Phase 3 clinical trials of teprotumumab, an investigational medicine being developed by Horizon Therapeutics plc, will be presented during an oral plenary presentation at the 89th Annual Meeting of the American Thyroid Association (ATA) in Chicago on Oct. 31. The U.S. Food and Drug Administration is currently evaluating...
In Living Color: Extending Your Practice’s Reach Via Telehealth
The advent of smart phones has enabled patients to avoid lengthy travel and made languishing in waiting rooms a thing of the past as telehealth has become more and more common in endocrinology practices. Telehealth can help manage the kind of chronic conditions, such as hypothyroidism or diabetes, that are considered hallmarks of endocrinology. Such...
Targeting Patients with Pellets: A Look at Biodentical Hormones
Promoted to treat vague symptoms and conditions like “hormone imbalance,” custom-compounded bioidentical hormones are increasing in popularity — and problems. By the time the patient came into the care of endocrinologist Margaret Wierman, MD, she had already had her ovaries removed. She had presented to the obstetrics and gynecology department with very high testosterone levels...
While endocrinologists are fairly well versed in caring for transgender patients, primary care physicians need to better understand their roles and know when to seek the counsel and support of specialists. Studies estimate that 1.4 million adults in the U.S. – 0.6% of the population – identify as transgender, and as that number continues to...FDA Approves First Ready-to-Use Stable Liquid Glucagon for Severe Hypoglycemia
The U.S. Food and Drug Administration (FDA) recently approved a ready-to-use, room-temperature stable liquid glucagon for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages 2 years and above. Xeris Pharmaceuticals is marketing this new glucagon injection as GVOKE. GVOKE is the first glucagon product approved that can be administered via...
In the wake of the recall of hypoparathyroidism drug NATPARA, the drug’s manufacturer, Takeda, is working with the FDA to develop a Special Use Program. The program is intended to support patients previously prescribed NATPARA who are facing life-threatening complications as a result of discontinuation of NATPARA. Through this program, healthcare providers will be able...
The U.S. Food and Drug Administration last month approved semaglutide oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise. This is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States that does not need to be injected. GLP-1...
If you are looking for a resource to ensure your endocrinology practice is up to date with legal and medical news, want to ensure you are meeting your patients’ needs to the best of your ability, and wish to be aware of recent advances in endocrinology, then Endocrine News has the right tools for you. Our Practice page is dedicated to providing information that is helpful and insightful for those running an endocrinology practice. Here you will find a collection of articles that provide current, relevant and vital information to help with your decisions as you run your practice.
Stay Current with Recent Advances in Endocrinology
As new technology hits the medical world and new discoveries about the endocrine system are made, you need the right information to continue to provide your patients with skilled medical care. Here you will find updated news and information about advances in the field, consolidated into one convenient location to help you save time while staying current. Rather than monitoring several news sites and digging for pertinent information, you can simply visit one page and have it all at your fingertips — saving you time as you run a busy practice.
See Clinical Endocrinology News That’s Relevant to Your Practice
On Endocrine News, you will also find the clinical news specific to the field of endocrinology that will help you make the best possible decisions for your clinic and your patients. From recent discoveries to research studies, you will have access to the most accurate and recent information available in the field. All of the reports, results and studies you need to see are here for you to search.
Improve Your Practice with Industry-Specific Tips and Tricks
In addition to the technical and medical industry research and reports you will find here, Endocrine News has the resources you need to keep your practice profitable and effective. From legal advice and tips to time management and patient interaction recommendations, you’ll find advice, insight and more that will help you run an efficient clinic that keeps your patients’ needs at the forefront of all you do.
